To date, about 50 different CLDN16 mutations have been identified in FHHNC patients in the coding regions of all four domains (http://www.hgmd.cf.ac.uk). Here, CLDN16 is linked to familial primary hypomagnesemia with hypercalciuria and nephrocalcinosis.